teclistamab,talquetamab,daratumumab,pomalidomide
genmab,janssen
['talquetamab', 'mmsm', 'daratumumab', 'trimm-2']
congress #eha2023 | speaks about trimm-2 results: talquetamab + daratumumab in rrmm. n=65. orr was 71.4% (57.1% vgpr; 42.9% cr) at 0.4mg/kg qw. orr=84.0% in 0.8 mg/kg q2w (74% vgpr; 52% cr). responses deepened over time. #mmsm #myeloma 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma